Lunesta 1mg 100tab.
87 $
Find the best price
Dosage form
- Tablets: 1 mg of eszopiclone in each tablet.
- Packaging: 100 tablets.
Please note that the appearance of the packaging may vary depending on the manufacturer and region of sale.
Active ingredient
Eszopiclone is a non-benzodiazepine hypnotic from the cyclopyrrolone class that interacts with GABA receptors to promote sleep.
Dosage
- Recommended initial dose for adults: 1 mg before bedtime.
- If necessary: the dose can be increased to 2-3 mg, depending on the patient's response and tolerability.
- Special groups of patients: for the elderly or patients with liver disease, it is recommended to start with 1 mg, avoiding dose increases.
- How to use: take immediately before bedtime, ensuring the possibility of a good night's rest (at least 7-8 hours).
Lunesta is the trade name for a medication containing the active ingredient eszopiclone, used for the treatment of insomnia.
Indications for Use:
- Insomnia: Difficulty falling asleep or maintaining sleep.
Contraindications:
- Known hypersensitivity to eszopiclone or any components of the drug.
- Severe hepatic dysfunction.
- Pregnancy and Breastfeeding: Use is not recommended due to insufficient safety data.
Side Effects:
- Common:
- Bitter or metallic taste in the mouth.
- Headache, drowsiness, dry mouth.
- Rare but Serious:
- Allergic reactions, including angioedema.
- Behavioral changes, hallucinations, suicidal thoughts.
- Other:
- Dizziness, nausea, vomiting.
- Impaired coordination, amnesia.
Special Instructions:
- Risk of Dependence and Abuse:
- Eszopiclone is classified as a controlled substance (C-IV) due to its potential for dependence and abuse.
- Complex Sleep Behaviors:
- There is a risk of patients engaging in activities such as driving, eating, or making phone calls during sleep, with no recollection afterward.
- Interaction with Alcohol and CNS Depressants:
- Co-administration with alcohol or other central nervous system (CNS) depressants can increase sedation and is not recommended.
- Discontinuation:
- Abrupt discontinuation after prolonged use may lead to withdrawal symptoms. Gradual dose reduction under medical supervision is recommended.
Precautions:
Before starting treatment with Lunesta, consult a healthcare provider to evaluate the appropriateness of therapy and determine the optimal dosage. Self-medication is strongly discouraged and may lead to adverse effects.
